Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

11 trials with published results (8%)

Research Maturity

60 completed trials (45% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.0%

8 terminated out of 133 trials

Success Rate

88.2%

+1.7% vs benchmark

Late-Stage Pipeline

12%

16 trials in Phase 3/4

Results Transparency

18%

11 of 60 completed with results

Key Signals

11 with results88% success

Data Visualizations

Phase Distribution

81Total
Not Applicable (32)
Early P 1 (1)
P 1 (13)
P 2 (19)
P 3 (10)
P 4 (6)

Trial Status

Completed60
Unknown36
Recruiting18
Terminated8
Withdrawn5
Active Not Recruiting3

Trial Success Rate

88.2%

Benchmark: 86.5%

Based on 60 completed trials

Clinical Trials (133)

Showing 20 of 20 trials
NCT06878768Not ApplicableCompleted

Translational Research GRICS-CineCardiac

NCT04638621Active Not RecruitingPrimary

Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study

NCT07241104Phase 1RecruitingPrimary

A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy

NCT03843255Active Not RecruitingPrimary

Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy

NCT07420907Recruiting

Study of the Progression of Chronic Cardiovascular Conditions

NCT06381466Phase 1TerminatedPrimary

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants.

NCT04331769Not ApplicableRecruiting

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

NCT05410873Phase 2CompletedPrimary

Examining the Effects of Mitochondrial Oxidative Stress in DCM

NCT04649034CompletedPrimary

Intraventricular Stasis In Cardiovascular Disease

NCT06464588Phase 1RecruitingPrimary

A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)

NCT03572660Phase 2RecruitingPrimary

Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM

NCT05237323Phase 3Completed

Micophenolate Mofetil Versus Azathioprine in Myocarditis

NCT02432092Recruiting

Pediatric Cardiomyopathy Mutation Analysis

NCT05564689Recruiting

Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy

NCT02915718Not ApplicableCompletedPrimary

A Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy

NCT04712136Not ApplicableCompleted

Healthy-related Quality of Life and Physical Activity of Children With Cardiac Malformations

NCT03057002Completed

UTSW HP [13-C] Pyruvate Injection in HCM

NCT06699056Recruiting

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

NCT06813443Recruiting

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

NCT06688396Not ApplicableRecruitingPrimary

Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)

Scroll to load more

Research Network

Activity Timeline